Table 3 Change in clinical parameters of the study population between baseline and follow up visit

Weight

65.7 (12.4)

65.3 (12.2)

0.020

−0.49 (3.90)

BMI

25.4 (4.1)

25.4 (4.2)

0.767

−0.03 (1.89)

Waist circumference

94.7 (10.3)

92.3 (10.2)

< 0.001

−2.48 (5.96)

Hip circumference

102.4 (8.1)

99.2 (8.1)

< 0.001

− 3.18 (5.09)

Systolic BP

140.8 (17.9)

135.5 (17)

< 0.001

−5.27 (19.26)

Diastolic BP

77.9 (9.8)

75.2 (9.7)

< 0.001

−2.71 (10.08)

HbA1c

7.2 (1)

7.1 (1.2)

0.016

−0.13 (1.00)

Total Cholesterol

4 (0.8)

4 (0.8)

0.510

0.03 (0.70)

HDL

1.3 (0.4)

1.3 (0.4)

0.987

0.00 (0.21)

LDL

2 (0.7)

2 (0.6)

0.533

0.02 (0.61)

TG

1.4 (0.7)

1.4 (0.6)

0.359

−0.03 (0.62)

Muscle Mass (kg/m2)

6.3 (1.3)

5.6 (1.5)

< 0.001

−0.67 (1.15)

Hand Grip strength (kg)

25.6 (8.1)

24.6 (8.1)

< 0.001

−0.58 (7.76)

Gait Speed (m/sec)

1.02 (0.17)

0.98 (0.2)

< 0.001

− 0.04 (0.19)

PASE, Mean (SD)

121 (80.6)

121.8 (82.8)

0.893

0.36 (88.45)

 Domain 1

14.8 (1.7)

15 (1.4)

0.192

0.15 (1.82)

 Domain 2

15.3 (1.8)

16.2 (1.3)

< 0.001

0.91 (1.85)

 Domain 3

12.8 (3.1)

14.4 (2.4)

< 0.001

2.20 (3.19)

 Domain 4

15.4 (1.9)

15.9 (1.1)

< 0.001

−0.48 (2.16)

IPAQ Total MET score

2624.4 (3043.2)

2276.9 (3327.3)

0.073

−347.5 (3510.3)